Search published articles


Showing 3 results for Breast Cancer

Zahra Eslami Samarin, Mohammad Tahmaseb, Abbas Ghaderi,
Volume 2, Issue 3 (12-2015)
Abstract

Breast cancer is the most common cancer worldwide and is the second leading cause of death in women after lung cancer. Micro RNAs (miRNAs) are among endogenous factors which are involved in many types of cancers, including breast cancer. Single nucleotide polymorphism (SNP) in the miRNAs, might change their biological activities such as their effects on oncogenes and tumor suppressor genes. Therefore some of miRNA’s SNPs are associated with the risk of different types of cancer, including breast cancer. The aim of this study was to evaluate the correlation between SNP rs11614913 in mir196a2 and the risk of breast cancer. SNP rs11614913 in hsa-miR-196a2 analyzed in 100 breast cancer cases and 100 controls in women living in southern Iran. Polymorphism was identified by the PCR-RFLP method. The PCR product was digested with TaaI restriction enzyme which produced two bands with the length of 187bp and 196bp. The data from this case –control study were analyzed using odds ratios (ORs) with 95% confidence intervals (CIs) to reveal the associations of SNPs in miRNAs with breast cancer susceptibility. The C allele frequencies in patients and controls for miR-196a2 were 0.74 and 0.75, respectively. The genotype frequencies of TT, TC, and CC were 0.05, 0.42, and 0.53 for the patients and 0.06, 0.38, and 0.56 for the controls, respectively. Statistical analysis showed that the genetic frequencies for this SNP were in Hardy-Weinberg equilibrium (p>0.05). The results of this study indicated no significant association between SNP rs11614913 in mir196a2 and the risk of breast cancer. 


Hesane Hassanpour, Mohammad Shokrzadeh Lamuki, Reza Tabari, Fatemeh Rezaee, Fatereh Rezaee,
Volume 5, Issue 2 (9-2018)
Abstract

With the increase of cancer disease and the side-effects of the current treatments, researchers are attempting to find methods with less side-effect. The fern Adiantum capillus-veneris L. has triterpenoid compounds which have anti-tumor characteristics. This study aims to investigate the fatal effect of the extract of this plant on breast cancer (MCF-7) and normal (MRC-5) cell lines using MTT method. A. capillus-veneris specimens were collected from Marzoon Abad Village and were dried at the temperature of 40° C by the use of Soxhlet and Ethanol % 96. Hydroalcoholic extract was produced from the aerial and underground parts of this plant and 3 fractions, i.e., Hexane, Chloroform and Ethyl acetate, were prepared from the extract. The compounds of the plant extract were identified by GC-Mass. The results demonstrate the presence of polyphenolic compounds, terpenoid, fatty acids, wax, alkaloid, N-oxide and fibers, with strong antioxidant effect. The results of the MTT test proved that this extract had a dose-depending fatal effect on the MCF-7 cells and is capable of eradicating the cancer cells. On the other hand, its effect on cancer cells is more than its effect on normal cells. Also, IC50 in both of cell lines induced by the extracts of aerial and underground parts showed a significant difference. The fatal characteristics of the extract are comparable with the cisplatin anti-cancer drug.
 
Dr. Zohreh Jahanafrooz,
Volume 11, Issue 4 (2-2025)
Abstract

Breast cancer is the most frequently diagnosed cancer in women. Triple-negative breast cancer (TNBC) is a kind of breast cancer that does not have any of the receptors that are commonly found in breast cancer. This study aimed to evaluate differentially expressed genes (DEGs) and their related microRNAs (miRNAs) in TNBC. GSE113865 and GSE154255 were selected from GEO database. DEGs and differentially expressed miRNAs between normal and TNBC tissues were identified via GEO2R online tools and R program. STRING was used to construct a protein–protein interaction (PPI) network of DEGs. The hub genes, obtained using the cytoHubba plugin in Cytoscape. We used R program and Enrichr database to enrichment analysis of hub genes. Then intersection of predicted hub gene's miRNAs and differentially expressed miRNAs was investigated. UBE2C and SAA1 were the highest upregulated and downregulated genes, respectively. Six main hub genes were identified, including CDC20, DLGAP5, TPX2, UBE2C, TK1, and CDC45. All the mentioned genes were upregulated and enriched in cell cycle progression. Some hub genes such as TPX2, UBE2C, and TK1 were targeted by differentially expressed miRNAs (miR-3679 and miR-4530). In conclusion, knockdown of hub genes could be a targeted therapy for TNBC. 
 

Page 1 from 1     

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



© 2025 CC BY-NC 4.0 | Nova Biologica Reperta

Designed & Developed by : Yektaweb